BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 38137567)

  • 1. Expression of Serpin Family E Member 1 (SERPINE1) Is Associated with Poor Prognosis of Gastric Adenocarcinoma.
    Lv J; Yu C; Tian H; Li T; Yu C
    Biomedicines; 2023 Dec; 11(12):. PubMed ID: 38137567
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomograms combined with
    Li XC; Wang S; Zhu JR; Wang YP; Zhou YN
    Transl Cancer Res; 2020 Jul; 9(7):4393-4412. PubMed ID: 35117805
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Global transcriptomic analysis identifies
    Xu B; Bai Z; Yin J; Zhang Z
    PeerJ; 2019; 7():e7091. PubMed ID: 31218131
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weighted correlation network analysis identifies FN1, COL1A1 and SERPINE1 associated with the progression and prognosis of gastric cancer.
    Zhao Q; Xie J; Xie J; Zhao R; Song C; Wang H; Rong J; Yan L; Song Y; Wang F; Xie Y
    Cancer Biomark; 2021; 31(1):59-75. PubMed ID: 33780362
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SERPINE1 as a cancer-promoting gene in gastric adenocarcinoma: facilitates tumour cell proliferation, migration, and invasion by regulating EMT.
    Yang JD; Ma L; Zhu Z
    J Chemother; 2019; 31(7-8):408-418. PubMed ID: 31724495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of pivotal genes associated with the prognosis of gastric carcinoma through integrated analysis.
    Ma Z; Xu J; Ru L; Zhu W
    Biosci Rep; 2021 Apr; 41(4):. PubMed ID: 33754626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The expression of SERPINE1 in colon cancer and its regulatory network and prognostic value.
    Wang Y; Wang J; Gao J; Ding M; Li H
    BMC Gastroenterol; 2023 Feb; 23(1):33. PubMed ID: 36755247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Data mining combines bioinformatics discover immunoinfiltration-related gene SERPINE1 as a biomarker for diagnosis and prognosis of stomach adenocarcinoma.
    Zhai Y; Liu X; Huang Z; Zhang J; Stalin A; Tan Y; Zhang F; Chen M; Shi R; Huang J; Wu C; Wu Z; Lu S; You L; Wu J
    Sci Rep; 2023 Jan; 13(1):1373. PubMed ID: 36697459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer.
    Chen S; Li Y; Zhu Y; Fei J; Song L; Sun G; Guo L; Li X
    J Oncol; 2022; 2022():2647825. PubMed ID: 35132319
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of
    Li L; Li F; Xu Z; Li L; Hu H; Li Y; Yu S; Wang M; Gao L
    Front Pharmacol; 2023; 14():1213891. PubMed ID: 37680718
    [No Abstract]   [Full Text] [Related]  

  • 11. Genome-scale analysis identifies SERPINE1 and SPARC as diagnostic and prognostic biomarkers in gastric cancer.
    Liao P; Li W; Liu R; Teer JK; Xu B; Zhang W; Li X; Mcleod HL; He Y
    Onco Targets Ther; 2018; 11():6969-6980. PubMed ID: 30410354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NAMPT, GRN, and SERPINE1 signature as predictor of disease progression and survival in gliomas.
    Vachher M; Arora K; Burman A; Kumar B
    J Cell Biochem; 2020 Apr; 121(4):3010-3023. PubMed ID: 31710121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration.
    Ye Y; Ge O; Zang C; Yu L; Eucker J; Chen Y
    Technol Cancer Res Treat; 2022; 21():15330338221080977. PubMed ID: 35254147
    [No Abstract]   [Full Text] [Related]  

  • 14. CDCA8 as an independent predictor for a poor prognosis in liver cancer.
    Shuai Y; Fan E; Zhong Q; Chen Q; Feng G; Gou X; Zhang G
    Cancer Cell Int; 2021 Mar; 21(1):159. PubMed ID: 33685433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cuproptosis-related gene SERPINE1 is a prognostic biomarker and correlated with immune infiltrates in gastric cancer.
    Feng L; Li G; Li D; Duan G; Liu J
    J Cancer Res Clin Oncol; 2023 Sep; 149(12):10851-10865. PubMed ID: 37318594
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Overexpression of GUCY1A2 Correlates With Poor Prognosis in Gastric Cancer Patients.
    Li X; Chen X; Hu X; Shen Y; Xu R; Wu L; Shen X
    Front Oncol; 2021; 11():632172. PubMed ID: 34113559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of DGKI in Gastric Cancer Predicts Poor Prognosis.
    Huang C; Zhao J; Luo C; Zhu Z
    Front Med (Lausanne); 2020; 7():320. PubMed ID: 32733904
    [No Abstract]   [Full Text] [Related]  

  • 18. Expression of LOX Suggests Poor Prognosis in Gastric Cancer.
    Zhu J; Luo C; Zhao J; Zhu X; Lin K; Bu F; Yu Z; Zou F; Zhu Z
    Front Med (Lausanne); 2021; 8():718986. PubMed ID: 34595188
    [No Abstract]   [Full Text] [Related]  

  • 19. The Prognostic Significance and Gene Expression Characteristics of Gastric Signet-Ring Cell Carcinoma: A Study Based on the SEER and TCGA Databases.
    Ma J; Meng Y; Zhou X; Guo L; Fu W
    Front Surg; 2022; 9():819018. PubMed ID: 35372476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel diagnostic biomarkers of oxidative stress, immune- infiltration characteristics and experimental validation of SERPINE1 in colon cancer.
    Yuan K; Hu D; Mo X; Zeng R; Wu B; Zhang Z; Hu R; Wang C
    Discov Oncol; 2023 Nov; 14(1):206. PubMed ID: 37980291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.